SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

11118	Companies
244800	Keywords
172882	Articles
131991	Press releases

Home
Companies
SANOFI-AVENTIS

BRIEF

published on 06/04/2026 at 10:12, 3 months 29 days ago

Sanofi Introduces 2026 Global Employee Stock Purchase Plan

Shareholding Stock Purchase Plan Sanofi Employee Shares Global Initiative
PRESS RELEASE

published on 06/04/2026 at 10:07, 3 months 29 days ago

Press Release: Sanofi launches 2026 global employee stock purchase plan
Sanofi launches Action 2026 global employee stock purchase plan involving 75,000 employees in 52 countries. Employees offered discounted shares with free matching shares and limited purchase amount. Eligibility conditions and holding periods apply

Shares Sanofi Global Employee Stock Purchase Plan Action 2026
BRIEF

published on 05/28/2026 at 07:05, 4 months 6 days ago

Sanofi's venglustat under priority review by the FDA for type 3 Gaucher disease

FDA Sanofi Venglustat Gaucher's Disease Priority Examination
BRIEF

published on 05/28/2026 at 07:05, 4 months 6 days ago

Sanofi's Venglustat Granted Priority Review for Type 3 Gaucher Disease

Sanofi FDA Review Venglustat Gaucher Disease Neurological Treatment
PRESS RELEASE

published on 05/28/2026 at 07:00, 4 months 6 days ago

Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease
Sanofi's venglustat granted priority review by FDA for treating type 3 Gaucher disease. Potential first US therapy for neurological manifestations with target action date on November 25, 2026

FDA Sanofi Venglustat Gaucher Disease Neurological Manifestations
BRIEF

published on 05/19/2026 at 18:42, 4 months 14 days ago

Sanofi Reports Voting Rights and Share Information for April 2026

Voting Rights French Commercial Code Shares Sanofi April 2026
PRESS RELEASE

published on 05/19/2026 at 18:37, 4 months 14 days ago

Sanofi: Information concerning the total number of voting rights and shares - April 2026
Sanofi discloses total voting rights and shares information as per French Commercial Code and French stock market authority regulations

French Commercial Code Total Voting Rights Shares Information Sanofi Stock Market Authority
BRIEF

published on 05/18/2026 at 21:35, 4 months 15 days ago

Sanofi announces the superiority of efdoralprin alfa in the treatment of DAAT

Sanofi Phase 2 DAAT Efdoralprin Alfa Recombinant Treatment
PRESS RELEASE

published on 05/18/2026 at 21:30, 4 months 15 days ago

Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD
ElevAATe phase 2 study shows efdoralprin alfa surpassing traditional therapy in achieving and maintaining fAAT levels in AATD patients with emphysema. Results presented at 2026 ATS International Conference

Efdoralprin Alfa ElevAATe FAAT Levels AATD Emphysema
BRIEF

published on 04/24/2026 at 20:35, 5 months 8 days ago

Sanofi Prices €2.3 Billion in Bond Offering

Corporate Finance Bond Issue Sanofi Fixed-rate Notes Euro Medium Term Note

Accesswire

Published on 10/03/2026 at 02:35, 10 hours 29 minutes ago

Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 17:45, 19 hours 19 minutes ago

Sparton Provides Status Update
Published on 10/02/2026 at 13:50, 23 hours 14 minutes ago

AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day ago

Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day ago

Alaska Energy Metals Appoints Independent Director, Thomas Benson

View all ACCESSWIRE

EQS Group

Published on 10/02/2026 at 23:55, 13 hours 9 minutes ago

IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 16 hours 40 minutes ago

EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 17 hours 18 minutes ago

innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 18:00, 19 hours 4 minutes ago

EQS-Adhoc: AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)
Published on 10/02/2026 at 18:00, 19 hours 4 minutes ago

AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)

Les Echos

Published on 10/02/2026 at 17:45, 19 hours 19 minutes ago

Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:30, 19 hours 34 minutes ago

Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/01/2026 at 19:00, 1 day 18 hours ago

AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 18:40, 1 day 18 hours ago

Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:05, 1 day 18 hours ago

Covivio - Information on total number of voting rights and share capital

View all LES ECHOS COMFI WIRE